Pour Ludek,...,Bila Jelena S,...,(broj koautora 16) (2024) Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study, HAEMATOLOGICA, vol. 109, br. 3, str. 895-905 (Article)